Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 2:30 PM
Ignite Modification Date: 2025-12-25 @ 1:04 PM
NCT ID: NCT02163759
Term: Hypoalbuminaemia
Organ System: Metabolism and nutrition disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA v23.0
Notes: None
Study: NCT02163759
Study Brief: A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 0 0 72 View
EG001 0 0 142 View
EG002 1 1 144 View